Your search returned 2 results.

Results
	1.	A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma. [electronic resource] by Goy, André Hernandez-Ilzaliturri, Francisco J Kahl, Brad Ford, Peggy Protomastro, Ewelina Berger, Mark Producer: 20150818 In: Leukemia & lymphoma vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma. [electronic resource] by Feldman, Tatyana Mato, Anthony R Chow, Kar F Protomastro, Ewelina A Yannotti, Kara M L Bhattacharyya, Pritish Yang, Xiao Donato, Michele L Rowley, Scott D Carini, Carolanne Valentinetti, Marisa Smith, Judith Gadaleta, Gabriella Bejot, Coleen Stives, Susan Timberg, Mary Kdiry, Sabrina Pecora, Andrew L Beaven, Anne W Goy, Andre Producer: 20140810 In: British journal of haematology vol. 166 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search